Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|April 23, 2022
Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological FeaturesMohamed S Mohamed, Anton Johansson, Jörgen Jonsson, et al.
Clinical Pharmacology and Therapeutics|October 21, 2024
Ketamine and Esketamine in Clinical Trials: FDA-Approved and Emerging Indications, Trial Trends With Putative Mechanistic ExplanationsKsenia A Vekhova, Eugenia D Namiot, Jörgen Jonsson, et al.
Nature Reviews. Drug Discovery|September 3, 2020
Soluble ligands as drug targetsMisty M Attwood, Jörgen Jonsson, Mathias Rask-Andersen, et al.
Neurobiology of Disease|March 1, 2026
Integrative transcriptomic meta-analysis reveals immune, synaptic, and non-coding RNA dysregulation in bipolar disorder across brain and bloodAleksandra Panina, Aleksandr V Sokolov, Jörgen Jonsson, et al.
Frontiers in Psychiatry|May 30, 2024
Depression proteomic profiling in adolescents with transcriptome analyses in independent cohortsAleksandr V Sokolov, Muataz S Lafta, Didi O T Nordberg, et al.
Frontiers in Pharmacology|August 20, 2025
Statins regulate kinase signaling by causing changes in phosphorylation, rather than through changes in gene expression or direct inhibition: evidence in colorectal cancerFrancisco Alejandro Lagunas-Rangel, Jörgen Jonsson, Ludmila Jackevica, et al.
Scientific Reports|April 26, 2017
SLC10A4 regulates IgE-mediated mast cell degranulation in vitro and mast cell-mediated reactions in vivoHanna Pettersson, Behdad Zarnegar, Annika Westin, et al.
Clinical Epigenetics|July 4, 2020
meQTL and ncRNA functional analyses of 102 GWAS-SNPs associated with depression implicate HACE1 and SHANK2 genesDiana M Ciuculete, Sarah Voisin, Lara Kular, et al.
Frontiers in Behavioral Neuroscience|April 15, 2015
Conditional targeting of medium spiny neurons in the striatal matrixBjörn Reinius, Martina Blunder, Frances M Brett, et al.
British Journal of Clinical Pharmacology|May 10, 2021
Recent developments of HDAC inhibitors: Emerging indications and novel moleculesAndrey D Bondarev, Misty M Attwood, Jörgen Jonsson, et al.
Pageof 2